AstraZeneca’s Epanova: Third In Omega-3 Market, Potentially First With Larger Population Claim
This article was originally published in The Pink Sheet Daily
Executive Summary
Fish oil treatment is the first to offer a dosing regimen of as few as two capsules, once a day, with our without food, AstraZeneca said.